Medtronic's automated insulin delivery system with SmartGuard technology — auto-correction boluses every 5 minutes, a 100 mg/dL adjustable target, and the disposable, no-calibration Simplera Sync sensor. Now cleared with an all-in-one CGM and simplified setup.
Device specifications change frequently — always verify current information directly with the manufacturer before making any decisions. Full disclaimer.
New to the MiniMed 780G? Start here.
The MiniMed 780G is Medtronic's automated insulin delivery system. Its SmartGuard technology adjusts basal insulin every 5 minutes and delivers automatic correction boluses — up to every 5 minutes — to address highs the basal adjustment alone doesn't cover. It targets an adjustable glucose setpoint (as low as 100 mg/dL) and, in the newer configuration, runs on the disposable, no-calibration Simplera Sync sensor with a simplified one-press insertion. It's a tubed pump using replaceable reservoirs and infusion sets.
SmartGuard adjusts basal every 5 minutes based on CGM data and predicted glucose, and delivers automatic correction boluses to handle highs. The auto-correction feature is a defining characteristic of the 780G's automation.
The 780G allows an adjustable glucose target as low as 100 mg/dL — a relatively aggressive setpoint among AID systems, associated in Medtronic's data with tighter control when used with recommended settings.
The newer 780G configuration uses Simplera Sync — a disposable, all-in-one, no-calibration sensor about half the size of Guardian, with a simple one-press applicator. A meaningful reduction in daily burden versus earlier Guardian sensors.
Beyond basal modulation, the 780G can deliver automatic correction boluses as often as every 5 minutes when it predicts glucose will run high — helping to blunt post-meal excursions without a manual correction.
The 780G's signature is aggressive automation: a 100 mg/dL target and automatic corrections as often as every five minutes, now paired with a disposable, no-calibration sensor and one-press insertion.
— Juicebox Podcast MiniMed 780G GuideBasal adjustment every 5 minutes plus automatic correction boluses up to every 5 minutes. Adjustable target as low as 100 mg/dL. Aggressive automation profile among commercial AID systems.
Simplera Sync in the newer configuration — disposable, no calibration, one-press insertion, ~half the size of Guardian. Earlier configurations used Guardian 4. Confirm which sensor is supplied in your region.
Medtronic recommends specific settings for best results — commonly a 100 mg/dL target and an active insulin time around 2 hours. Optimizing these is a major driver of outcomes on the 780G.
Tubed pump with replaceable reservoir and infusion set. Data via CareLink. Confirm current age indications and configuration availability before prescribing.
The 780G rewards good settings. Its aggressive automation — a low target and frequent auto-corrections — performs best when active insulin time and target are dialed in per Medtronic's guidance. Here's how the system behaves day to day.
Medtronic's guidance commonly points to a 100 mg/dL target and an active insulin time around 2 hours for best results. These two levers strongly influence how aggressively SmartGuard automates. Optimizing them is the single biggest factor in 780G outcomes.
You still announce meals and bolus for carbohydrates. SmartGuard's auto-corrections supplement your meal boluses by cleaning up highs, but pre-bolusing and accurate carb entry still matter for post-meal control.
A temporary higher target is used to reduce insulin delivery around exercise, lowering hypoglycemia risk during activity. Set it before activity and remove it afterward, as with other AID systems' activity modes.
With Simplera Sync, no fingerstick calibration is required, and insertion is a single press with no separate transmitter to recharge — a substantial simplification versus the older Guardian workflow.
The two highest-impact levers. Medtronic guidance commonly cites a 100 mg/dL target and ~2-hour active insulin time for optimal SmartGuard performance. Patients not hitting goals are often running a higher target or longer AIT than recommended.
Auto-corrections supplement but don't replace good meal bolusing. Reinforce pre-bolusing and accurate carb counting. SmartGuard cleans up, but starting the meal well still drives post-prandial outcomes.
For patients moving from Guardian 4 to Simplera Sync, re-train insertion (one-press, disposable, no transmitter). The workflow is simpler but different. Confirm which sensor the patient's system uses.
As a tubed pump, the 780G depends on reliable infusion sets. Counsel on site rotation and timely set changes — set failures are a leading cause of unexplained hyperglycemia in tubed-pump users.
The MiniMed 780G has a substantial evidence base and a distinctive automation profile. Understanding how SmartGuard works — and how settings drive its behavior — explains why the 780G performs the way it does.
Basal adjustment every 5 minutes plus automatic correction boluses up to every 5 minutes. Adjustable target down to 100 mg/dL. Aggressive automation profile toward tight control.
Simplera Sync (newer): disposable, no calibration, one-press, ~half Guardian size. Guardian 4 (earlier config): 7-day, reusable transmitter. Confirm regional availability.
Commonly cited: 100 mg/dL target, ~2-hour active insulin time. These levers drive SmartGuard aggressiveness and are the primary determinant of outcomes.
Meal announcement/bolus, infusion set changes (2–3 days), sensor changes, reservoir refills, temp targets for exercise. SmartGuard reduces but doesn't remove these.
Pivotal and large real-world CareLink datasets report strong time-in-range with recommended settings. Interpret manufacturer data alongside independent literature; outcomes are settings-dependent.
Tubed pump, replaceable reservoir/infusion set. CareLink for clinician review; app-based patient access. Confirm current age indications and configuration.